Senator Sheldon Whitehouse sold shares of Danaher Corp (DHR) valued between $1,000 and $15,000 on August 27, 2025. The transaction was reported six days later, on September 2, 2025, in compliance with the STOCK Act's 30-day reporting requirement.
This sale was executed through Whitehouse's own account. The STOCK Act of 2012 mandates that members of Congress disclose stock transactions within 30 days to enhance transparency and prevent insider trading.
Danaher Corp, based in Washington, D.C., operates in the Life Sciences Tools & Services industry. The company designs, manufactures, and markets a range of professional and medical products. With a market capitalization of $156.7 billion, Danaher has a P/E ratio of 44.73 and an EPS of 4.86. The firm employs 61,000 people and operates through three segments: Biotechnology, Life Sciences, and Diagnostics.
The upcoming earnings reports are scheduled for April 19, 2026, and July 19, 2026, with estimated EPS of $2.02 and $1.98, respectively.
Congressional trading disclosures provide insights into the financial activities of elected officials. While these transactions are legal when properly reported, investors should view them as one of many data points rather than direct investment signals.